Study Supports Soy Isoflavones and Cocoa Flavonoids for Type 2 Diabetes
Compared to placebo, cocoa and soy supplementation improved insulin and cholesterol markers in type 2 diabetic women.
In a one-year study, type 2 diabetics experienced improved heart health biomarkers when assigned to daily consumption of cocoa flavonoids and soy isoflavones.
U.K. researchers assigned 93 postmenopausal women with type 2 diabetes to a daily combination of two highly standardized ingredients: SoyLife from Frutarom Ltd. (Haifa, Israel) featuring 100 mg of soy isoflavones and Acticoa from Barry Callebaut (Zurich, Switzerland) featuring 850 mg of flavan-3-ols.
Compared to placebo, the cocoa and soy supplementation improved insulin resistance, decreased insulin levels, improved ratios of total cholesterol to HDL cholesterol, and reduced LDL cholesterol levels in subjects.
Both Frutarom and Barry Callebaut supported the study, now published in the journal Diabetes Care.
Sirio Pharma launches line of ready-to-market organic gummies and softgels called PureOrganix
August 26th 2024The new line is made up of three gummies and one softgel that are formulated to meet stringent EU-Organic certification criteria, and target women’s health, metabolic health, and heart health.
SourceOne Global Partners to distribute Qualitas Health’s microalgae omega-3 ingredient globally
August 15th 2024SourceOne Global Partners has announced a partnership with Qualitas Health Inc., (dba iwi life) to introduce the company’s trademarked AlmegaPL microalgae omega-3 ingredient to the global marketplace.
